Cargando…

Can a Two-Dose Influenza Vaccine Regimen Better Protect Older Adults? An Agent-Based Modeling Study

Older adults (age ≥ 65) are at high risk of influenza morbidity and mortality. This study evaluated the impact of a hypothetical two-dose influenza vaccine regimen per season to reduce symptomatic flu cases by providing preseason (first dose) and mid-season (second dose) protection to offset waning...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Katherine V., Krauland, Mary G., Harrison, Lee H., Williams, John V., Roberts, Mark S., Zimmerman, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697266/ https://www.ncbi.nlm.nih.gov/pubmed/36366307 http://dx.doi.org/10.3390/vaccines10111799

Ejemplares similares

Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden
por: Krauland, Mary G., et al.
Publicado: (2022)

Impact of Low Rates of Influenza on Next-Season Influenza Infections
por: Krauland, Mary G., et al.
Publicado: (2022)

Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen
por: Stefánsson, Bergur V., et al.
Publicado: (2011)

Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States
por: Lee, Kyueun, et al.
Publicado: (2021)

Influenza: Can we cope better with the unpredictable?
por: Dos Santos, Gaël, et al.
Publicado: (2015)

99. Immune Responses to Influenza Vaccines in Children and Young Adults
por: Williams, Katherine V, et al.
Publicado: (2021)

Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?
por: Matrajt, Laura, et al.
Publicado: (2020)

150. Relative Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults—United States, 2015–2017
por: Doyle, Joshua, et al.
Publicado: (2018)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

1012. Protective Effects of Maternal Influenza Vaccine during Pregnancy and Breastfeeding on Risk of Infant Influenza
por: Rick, Anne-Marie, et al.
Publicado: (2023)

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
por: Krammer, Florian, et al.
Publicado: (2018)

Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy
por: Shelley, L.E.A., et al.
Publicado: (2017)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

Making Better Influenza Virus Vaccines?
por: Palese, Peter
Publicado: (2006)

Better influenza vaccines: an industry perspective
por: Chen, Juine-Ruey, et al.
Publicado: (2020)

Universal influenza vaccines: Shifting to better vaccines
por: Berlanda Scorza, Francesco, et al.
Publicado: (2016)

Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults
por: France, Glenson, et al.
Publicado: (2018)

Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

530 Disease Modulation in Older Adults Vaccinated with High-Dose Versus Standard-Dose Influenza Vaccine
por: Talbot, H. Keipp, et al.
Publicado: (2014)

Sublingual Vaccination with Live Influenza Virus Induces Better Protection Than Oral Immunization in Mice
por: Mao, Jie, et al.
Publicado: (2022)

1168. Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

The influenza vaccines roadmap – A better future through improved influenza vaccines
por: Hart, Peter, et al.
Publicado: (2021)

Among once-daily regimens, single tablet regimens (STRs) are associated with better adherence
por: Murri, R, et al.
Publicado: (2012)

How Can We Solve the Enigma of Influenza Vaccine–Induced Protection?
por: Neuzil, Kathleen M.
Publicado: (2015)

Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children
por: Van Buynder, P. G., et al.
Publicado: (2010)

Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy
por: Chalichem, Nehru Sai Suresh, et al.
Publicado: (2020)

Emerging agents and regimens for AML
por: Liu, Hongtao
Publicado: (2021)

Influenza vaccination coverage: findings from immunization information systems
por: Zimmerman, Laura A, et al.
Publicado: (2007)

The impact of physical frailty on the response to inactivated influenza vaccine in older adults
por: Moehling, Krissy K., et al.
Publicado: (2020)

Antiviral Treatment among Older Adults Hospitalized with Influenza, 2006-2012
por: Lindegren, Mary Louise, et al.
Publicado: (2015)

Confronting an influenza pandemic with inexpensive generic agents: can it be done?
por: Fedson, David S
Publicado: (2008)

531 Split-virion compared to Subunit Influenza Trivalent Influenza Vaccines Has Greater Effectiveness in Older Adults
por: Talbot, H. Keipp, et al.
Publicado: (2014)

Older adults’ vaccine hesitancy: psychosocial predictors of influenza, pneumococcal, & shingles vaccine uptake
por: Nicholls, Louise Brown, et al.
Publicado: (2020)

A Novel Approach to Pharmacodynamic Assessment of Antimicrobial Agents: New Insights to Dosing Regimen Design
por: Tam, Vincent H., et al.
Publicado: (2011)

662 Missed opportunities for influenza vaccination among inpatients with influenza
por: Rao, Suchitra, et al.
Publicado: (2014)

1055 Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12
por: Sundaram, Maria, et al.
Publicado: (2014)

An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population
por: Fochesato, Anna, et al.
Publicado: (2022)

Emerging agents and regimens for multiple myeloma
por: Yang, Yang, et al.
Publicado: (2020)

Emerging agents and regimens for hepatocellular carcinoma
por: Zhu, Xiao-Dong, et al.
Publicado: (2019)

Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
por: Leggio, Massimo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1q3f4hqiuusjv792f9phla251c